TNFSF10 and neoplasm: Full-length TRAIL has recently been reported to kill tumour cells that are resistant to soluble TRAIL, suggesting a greater therapeutic potential of this form and indicating the existence of yet not understood mechanistic differences between the two TRAIL variants (Voelkel-Johnson et al, 2002; Seol et al, 2003).